Direct-Haler A/S is a privately owned drug delivery device company focusing on research & development and out-licensing of world-wide patented device technologies for pulmonary and nasal delivery
Direct-Haler has a flexible outlook on the development of the company's business, and in how their technology can be fully exploited and commercialized. The company are looking for business partnerships both concerning commercialization (route to market) and for accessing complementary technology to the DirectHaler(TM) technologies.